Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Charles River Laboratories Intl (NY: CRL ) 229.00 -3.10 (-1.34%) Official Closing Price Updated: 4:10 PM EDT, Apr 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Charles River Laboratories Intl < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally April 22, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing April 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call April 12, 2024 From Charles River Laboratories International, Inc. Via Business Wire Evaluating Charles River: Insights From 7 Financial Analysts March 18, 2024 Via Benzinga Forecasting The Future: 4 Analyst Projections For Charles River February 15, 2024 Via Benzinga Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology April 11, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics April 09, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River to Perform Plasmid Production for Ship of Theseus April 04, 2024 From Charles River Laboratories International, Inc. Via Business Wire Earnings Scheduled For February 14, 2024 February 14, 2024 Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion. Via Benzinga CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm April 02, 2024 From Bragar Eagel & Squire Via GlobeNewswire Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 April 01, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Publishes 2023 Corporate Citizenship Report March 27, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine March 21, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration March 14, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories to Present at Barclays Global Healthcare Conference March 12, 2024 From Charles River Laboratories International, Inc. Via Business Wire The Top 3 Healthcare Stocks to Buy in March 2024 March 07, 2024 There are still bargains to be had in the medical space. These are three top healthcare stocks to buy today. Via InvestorPlace Betting on Bitcoin: Does Coinbase Stock’s Surge Signal a Buy? March 07, 2024 vBitcoin has exploded higher over the past month setting an all-time record. That’s excellent news for Coinbase Global and COIN stock. Via InvestorPlace Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months March 06, 2024 Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions. Via Investor's Business Daily Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing February 21, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells February 20, 2024 From Charles River Laboratories International, Inc. Via Business Wire The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore. February 15, 2024 Looking for the next generational winner in healthcare stocks? These are three of the top prospects today. Via InvestorPlace Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday? February 14, 2024 The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation report in January, as investors refocused on corporate earnings. Via Benzinga Topics Economy Exposures Interest Rates Charles River Laboratories Stock Surges On Upbeat Annual Outlook, But This Analyst Is Concerned February 14, 2024 Charles River Laboratories Q4 2023 revenue: $1.01 billion, down 7.9% YoY, beating consensus. Analysts note mixed Q4 performance, keeping Outperform rating. Via Benzinga Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 14, 2024 Shares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list... Via Benzinga Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday February 14, 2024 U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test January 29, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors January 24, 2024 From Charles River Laboratories International, Inc. Via Business Wire Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call January 23, 2024 From Charles River Laboratories International, Inc. Via Business Wire Ten Big Losers To Start The Year. Tesla Isn't The Worst. January 16, 2024 Enphase Energy remains out of phase with the stock market. Via Investor's Business Daily Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing January 16, 2024 From Charles River Laboratories International, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.